Brandon Smith
Förmögenhet: 435 760 $ per 2026-09-30
Förmögenhet: 435 760 $ per 2026-09-30
Brandon S.
Smith is Chief Operating Officer at Prothena Corp.
Plc since 2021.
Formerly, Mr. Smith was Chief Operating Officer at Iconic Therapeutics, Inc. from 2017 to 2020, Senior VP and VP-Corporate Development & Strategy at Impax Laboratories LLC from 2012 to 2017, and Executive Director-Biosimilars Strategy at Amgen, Inc. from 2011 to 2012.
Education includes undergraduate studies at the University of Michigan and an MBA from McCombs School of Business.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
PROTHENA CORP. PLC 0,1 % | 2026-07-28 | 52 000 ( 0,1 % ) | 435 760 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| PROTHENA CORPORATION PLC | Verksamhetschef | 2021-09-29 |
| Företag | Position | Slut |
|---|---|---|
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunoconjugate proteins intended to translate scientific insight into breakthrough medicines for serious diseases | Verksamhetschef | 2020-01-01 |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Engages in development, manufacture and commercialization of generic and branded prescription pharmaceutical products | Företagsledare/Principal | 2017-01-01 |
| AMGEN INC. | Företagsledare/Principal | 2012-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Engages in development, manufacture and commercialization of generic and branded prescription pharmaceutical products | Health Technology |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunoconjugate proteins intended to translate scientific insight into breakthrough medicines for serious diseases | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prothena Corp. Plc
Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
McCombs School of Business
McCombs School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån